Zambia

in page functions
Total population (2013) 14,538,640
Birth cohort (2013) 624,919
Surviving Infants (surviving to 1 year per year, 2013) 584,671
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 56/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 89/1000
World Bank Index, IDA (2012) 3.44
Gross Nation Income (per capita US$, 2012) 1,350
Co-financing status (2013) Intermediate
No. of districts/territories (2012) 72

GAVI support for Zambia

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Health system strengthening (HSS) $2,722,653 $6,410,653 $2,722,653 100%
Immunisation services support (ISS) $3,864,060 $3,864,060 $3,864,060 100%
Injection safety support (INS) $689,237 $689,237 $689,237 100%
Measles (NVS) $650,878 $1,006,878 $632,553 97%
Penta (NVS) $50,754,137 $54,888,137 $52,378,016 103%
Pneumo (NVS) $19,948,843 $32,330,843 $19,095,130 96%
Rotavirus (NVS) $3,894,148 $7,266,648 $2,451,594 63%
Tetra DTP-Hib (NVS) $8,878,028 $8,878,028 $8,878,028 100%
Vaccine Introduction Grant $1,770,000 $1,770,000 $1,770,000 100%
Total $93,171,983 $117,104,483 $92,481,269

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Zambia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
78%

**
DTP3 - Official country estimates (2012) 78%
M:F sex ratio at birth (2013) 1.02
Household survey: DTP3 coverage for male (2007) 80.50%
Household survey: DTP3 coverage for female (2007) 78.90%
Household survey: Last DTP3 survey (2010) 93%
% districts achieving > 80% DTP3 coverage (2012) 69%
% districts achieving < 50% DTP3 coverage (2012) 6%
MCV WHO/UNICEF estimates (2012) 83%
Polio WHO/UNICEF estimates (2012) 83%

Breakdown of support

Non-vaccine support Vaccine support
10% 90%
$9,045,949 $83,435,317

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Zambia

27 November 2013

GAVI supported rotavirus vaccines introduced in Zambia

Following a successful pilot program delivering rotavirus vaccines as part of an integrated approach to diarrhoea prevention and control, in November 2013, Zambia rolled out GAVI-supported rotavirus vaccines nationwide. Rotavirus, the most common cause of severe and fatal diarrhoea in young children worldwide, takes the lives of over 3,600 Zambian children under five each year and accounts for approximately 40 percent of all under-five diarrhoeal deaths and hospitalisations. Zambia is the 18th GAVI-eligible country to introduce rotavirus vaccines in its national immunisation program. (credit VITAC-PATH)

12 November 2013

wpd.jpg

Pneumonia still responsible for one fifth of child deaths

Pneumonia remains the single biggest killer of children under five globally, claiming the lives of more than one million girls and boys every year. But pneumonia deaths are preventable. As countries mark World Pneumonia Day on 12 November, the GAVI Alliance, UNICEF and the World Health Organization (WHO) are highlighting essential actions that can help end child deaths from this disease.

12 July 2013

Pneumococcal vaccine

Zambia protects children against two major diseases

Pneumococcal and measles second dose vaccines to reach more than 360,000 infants in next 12 months, part of global acceleration in rollout of life-saving vaccines in developing countries.

close icon

modal window here